Currently, the share price for Bacil Pharma Ltd. is delayed. Login to view live prices.

Bacil Pharma Ltd.

BSE

-- ( -- %) 1D

Overview Fundamentals

Analyst Sentiment For Bacil Pharma Ltd.

There seem to be no recommendations on this stock from the analyst universe covered

Returns

Bacil Pharma Ltd.'s Info & Management

Bacil Pharma is engaged in operates as a pharmaceutical company the Company offers herbal extracts, heavy, medium, fine chemicals, and bulk intermediates.

Chief Financial Officer
Mr. Jayesh Ramchandra Patil
Company Secretary,Compliance Officer
Tak Bhavana Tak
Manager
Mr. Ganpat Dhondu Salekar

FAQs on Bacil Pharma Ltd.

What is the PB ratio of Bacil Pharma Ltd.?

The trailing twelve month (TTM) PB ratio of Bacil Pharma Ltd. is 17.76 as of March 18, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What is the ROE of Bacil Pharma Ltd.?

Bacil Pharma Ltd. reported an ROE of -5.11% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Bacil Pharma Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Bacil Pharma Ltd., Promoter held 10.6%, and the public held 89.4% of the total shares.

How to buy Bacil Pharma Ltd. Share?

You can easily buy shares of Bacil Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Bacil Pharma Ltd.?

The fair value of Bacil Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.